DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach

Journal Article · · Scientific Reports
 [1];  [1];  [1];  [1];  [1];  [2];  [1];  [1];  [1];  [3];  [1];  [1];  [1]
  1. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
  2. United States Army Medical Research Institute of Chemical Defense, Aberdeen, MD (United States)
  3. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States); Mental Illness Research, Education and Clinical Center, Palo Alto, CA (United States); Stanford University School of Medicine, CA (United States)

Nerve agents have experienced a resurgence in recent times with their use against civilian targets during the attacks in Syria (2012), the poisoning of Sergei and Yulia Skripal in the United Kingdom (2018) and Alexei Navalny in Russia (2020), strongly renewing the importance of antidote development against these lethal substances. The current standard treatment against their effects relies on the use of small molecule-based oximes that can efficiently restore acetylcholinesterase (AChE) activity. Despite their efficacy in reactivating AChE, the action of drugs like 2-pralidoxime (2-PAM) is primarily limited to the peripheral nervous system (PNS) and, thus, provides no significant protection to the central nervous system (CNS). This lack of action in the CNS stems from their ionic nature that, on one end makes them very powerful reactivators and on the other renders them ineffective at crossing the Blood Brain Barrier (BBB) to reach the CNS. In this report, we describe the use of an iterative approach composed of parallel chemical and in silico syntheses, computational modeling, and a battery of detailed in vitro and in vivo assays that resulted in the identification of a promising, novel CNS-permeable oxime reactivator. Additional experiments to determine acute and chronic toxicity are ongoing.

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
1823222
Report Number(s):
LLNL-JRNL--774440; 965098
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 11; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (55)

Preclinical Studies of Noncharged Oxime Reactivators for Organophosphate Exposure: NONCHARGED OXIME REACTIVATORS journal August 2013
Definitive Evidence for the Acute Sarin Poisoning Diagnosis in the Tokyo Subway journal May 1997
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology journal February 2005
A Novel Design of Artificial Membrane for Improving the PAMPA Model journal January 2008
A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties journal October 1956
A specific antidote against lethal alkylphosphate intoxication journal January 1956
VMD: Visual molecular dynamics journal February 1996
Analysis of a 10-ns Molecular Dynamics Simulation of Mouse Acetylcholinesterase journal August 2001
Clinical evaluation of pesticide exposure and poisonings journal April 1997
The role of excitotoxicity in organophosphorous nerve agents central poisoning journal June 1997
A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations journal August 2014
Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123 journal September 2009
Reaction profiles of the interaction between sarin and acetylcholinesterase and the S203C mutant: Model nucleophiles and QM/MM potential energy surfaces journal September 2010
Butyrylcholinesterase and G116H, G116S, G117H, G117N, E197Q and G117H/E197Q mutants: A molecular dynamics study journal September 2010
Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents journal November 2016
Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX journal November 2016
Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor journal August 2017
The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs journal November 2017
Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake journal September 2020
Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: A modified kinetic approach journal December 2010
History of chemical and biological warfare agents journal October 2005
Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase journal July 2006
Novel substituted phenoxyalkyl pyridinium oximes enhance survival and attenuate seizure-like behavior of rats receiving lethal levels of nerve agent surrogates journal January 2016
Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques journal September 2018
The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation journal September 2018
Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases journal March 2020
Pharmacokinetics of Three Oximes in a Guinea Pig Model and Efficacy of Combined Oxime Therapy journal May 2020
A High-Throughput Method for the Conversion of CO 2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for Quantification of 14 C via Accelerator Mass Spectrometry journal May 2003
Large-Scale First-Principles Molecular Dynamics Simulations with Electrostatic Embedding: Application to Acetylcholinesterase Catalysis journal November 2015
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents journal April 2018
Predicting a Drug’s Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data journal May 2017
Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity journal May 2017
Pharmacokinetic Evaluation of Brain Penetrating Morpholine-3-hydroxy-2-pyridine Oxime as an Antidote for Nerve Agent Poisoning journal February 2020
Toward Fully Automated High Performance Computing Drug Discovery: A Massively Parallel Virtual Screening Pipeline for Docking and Molecular Mechanics/Generalized Born Surface Area Rescoring to Improve Enrichment journal December 2013
Amidine−Oximes: Reactivators for Organophosphate Exposure journal May 2011
Imidazole Aldoximes Effective in Assisting Butyrylcholinesterase Catalysis of Organophosphate Detoxification journal February 2014
Syrian gas attack reinforces need for better anti-sarin drugs journal October 2013
Drug resistance in brain diseases and the role of drug efflux transporters journal July 2005
The ‘aromatic patch’ of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors journal October 1998
Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6 journal May 2016
New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases journal April 2011
Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases journal February 2012
Rational design, synthesis, and evaluation of uncharged, “smart” bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase journal March 2020
Synthesis and In Vitro and In Vivo Inhibition Potencies of Highly Relevant Nerve Agent Surrogates journal January 2012
Novel Brain-Penetrating Oxime Acetylcholinesterase Reactivators Attenuate Organophosphate-Induced Neuropathology in the Rat Hippocampus journal March 2019
Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase journal January 1999
Novel brain‐penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates journal May 2016
Evaluation of Microdosing to Assess Pharmacokinetic Linearity in rats Using Liquid Chromatography-Tandem mass Spectrometry journal December 2005
In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System journal October 2007
How to defeat a nerve agent journal January 2018
A Wrench in the Works of Human Acetylcholinesterase: Soman Induced Conformational Changes Revealed by Molecular Dynamics Simulations journal April 2015
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics journal October 2016
Analysis of Pralidoxime in Serum, Brain and CSF of Rats journal May 2009
In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley? journal April 2018
The Experimental Oxime K027—A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime journal May 2019